Search Results - "Razzouk, Bassem"

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial by Rubnitz, Jeffrey E, Prof, Inaba, Hiroto, MD, Dahl, Gary, Prof, Ribeiro, Raul C, Prof, Bowman, W Paul, Prof, Taub, Jeffrey, MD, Pounds, Stanley, PhD, Razzouk, Bassem I, MD, Lacayo, Norman J, MD, Cao, Xueyuan, PhD, Meshinchi, Soheil, MD, Degar, Barbara, MD, Airewele, Gladstone, MD, Raimondi, Susana C, Prof, Onciu, Mihaela, MD, Coustan-Smith, Elaine, MS, Downing, James R, Prof, Leung, Wing, Prof, Pui, Ching-Hon, Prof, Campana, Dario, Prof

“…Summary Background We sought to improve outcome in patients with childhood acute myeloid leukaemia (AML) by applying risk-directed therapy that was based on…”
Get full text

Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group by KASPERS, Gertjan J. L, ZIMMERMANN, Martin, HOVI, Liisa, MASCHAN, Alexei, BERTRAND, Yves, LEVERGER, Guy G, RAZZOUK, Bassem I, RIZZARI, Carmelo, SMISEK, Petr, SMITH, Owen, STARK, Batia, CREUTZIG, Ursula, REINHARDT, Dirk, GIBSON, Brenda E. S, TAMMINGA, Rienk Y. J, ALEINIKOVA, Olga, ARMENDARIZ, Hortensia, DWORZAK, Michael, HA, Shau-Yin, HASLE, Henrik

“…In pediatric relapsed acute myeloid leukemia (AML), optimal reinduction therapy is unknown. Studies suggest that liposomal daunorubicin (DNX; DaunoXome; Galen,…”
Get full text

Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group by Cooper, Todd M, Absalon, Michael J, Alonzo, Todd A, Gerbing, Robert B, Leger, Kasey J, Hirsch, Betsy A, Pollard, Jessica, Razzouk, Bassem I, Aplenc, Richard, Kolb, E Anders

“…Effective regimens are needed for children with relapsed acute myeloid leukemia (AML). AAML1421 is a phase I/II study of CPX-351, a liposomal preparation of…”
Get full text

Acute mixed lineage leukemia in children: the experience of St Jude Children’s Research Hospital by Rubnitz, Jeffrey E., Onciu, Mihaela, Pounds, Stanley, Shurtleff, Sheila, Cao, Xueyuan, Raimondi, Susana C., Behm, Frederick G., Campana, Dario, Razzouk, Bassem I., Ribeiro, Raul C., Downing, James R., Pui, Ching-Hon

“…To characterize the biology and optimal therapy of acute mixed-lineage leukemia in children, we reviewed the pathologic and clinical features, including…”
Get full text

Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia by Hijiya, Nobuko, Hudson, Melissa M, Lensing, Shelly, Zacher, Margie, Onciu, Mihaela, Behm, Fred G, Razzouk, Bassem I, Ribeiro, Raul C, Rubnitz, Jeffrey E, Sandlund, John T, Rivera, Gaston K, Evans, William E, Relling, Mary V, Pui, Ching-Hon

“…CONTEXT Little is known about the incidence of secondary neoplasms after 15 to 20 years in children and adolescents who were treated for acute lymphoblastic…”
Get full text

Pineal gland hypermetabolic involvement without central nervous system symptoms in a pediatric patient with primary nodular sclerosis subtype classical Hodgkin Lymphoma by Kokoska, Ryan E, Beltz, Eric E, Smith, Jodi L, Razzouk, Bassem I

“…This case report presents the first reported pediatric case of primary classical nodular sclerosing Hodgkin Lymphoma (HL) with pineal gland involvement,…”
Get full text

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia by JEHA, Sima, GAYNON, Paul S, RITCHEY, Kim, ALBANO, Edythe, ARCECI, Robert J, GOLDMAN, Stewart, GRIFFIN, Timothy, ALTMAN, Arnold, GORDON, Bruce, STEINHERZ, Laurel, WEITMAN, Steven, STEINHERZ, Peter, RAZZOUK, Bassem I, FRANKLIN, Janet, KADOTA, Richard, SHEN, Violet, LUCHTMAN-FONES, Lori, RYTTING, Michael, BOMGAARS, Lisa R, RHEINGOLD, Susan

“…To evaluate the efficacy and safety of clofarabine, a novel deoxyadenosine analog, in pediatric patients with refractory or relapsed acute lymphoblastic…”
Get full text

Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia by Kurt, Beth, Flynn, Patricia, Shenep, Jerry L., Pounds, Stanley, Lensing, Shelly, Ribeiro, Raul C., Pui, Ching‐Hon, Razzouk, Bassem I., Rubnitz, Jeffrey E.

“…BACKGROUND. The aim of this study was to determine whether antibiotic prophylaxis during periods of neutropenia reduced streptococcal (S. viridans) sepsis and…”
Get full text

Obesity in Survivors of Childhood Acute Lymphoblastic Leukemia and Lymphoma by RAZZOUK, Bassem I, ROSE, Susan R, HONGENG, Suradej, WALLACE, Dana, SMELTZER, Matthew P, ZACHER, Margie, PUI, Ching-Hon, HUDSON, Melissa M

“…We evaluated the long-term effects of treatment on the body mass index (BMI) of children with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma who…”
Get full text

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia by Cooper, Todd M., Alonzo, Todd A., Gerbing, Robert B., Perentesis, John P., Whitlock, James A., Taub, Jeffrey W., Horton, Terzah M., Gamis, Alan S., Meshinchi, Soheil, Loken, Michael R., Razzouk, Bassem I.

“…BACKGROUND The discovery of new, effective non–anthracycline‐based reinduction regimens for children with recurrent acute myeloid leukemia (AML) is critical…”
Get full text

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital by Pui, Ching-Hon, Sandlund, John T., Pei, Deqing, Campana, Dario, Rivera, Gaston K., Ribeiro, Raul C., Rubnitz, Jeffrey E., Razzouk, Bassem I., Howard, Scott C., Hudson, Melissa M., Cheng, Cheng, Kun, Larry E., Raimondi, Susana C., Behm, Frederick G., Downing, James R., Relling, Mary V., Evans, William E.

“…St Jude Total Therapy Study XIIIB for childhood acute lymphoblastic leukemia (ALL) incorporated more stringent risk classification, early intensification of…”
Get full text

Clinical Field Testing of an Enhanced-Activity Intervention in Hospitalized Children with Cancer by Hinds, Pamela S., PhD, RN, FAAN, Hockenberry, Marilyn, PhD, RN, PNP, FAAN, Rai, Shesh N., PhD, Zhang, Lijun, MS, Razzouk, Bassem I., MD, Cremer, Lola, PT, McCarthy, Kathy, BSN, Rodriguez-Galindo, Carlos, MD

“…Abstract This prospective, two-site, randomized, controlled pilot study assessed the feasibility of an enhanced physical activity (EPA) intervention in…”
Get full text

Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma by Fox, Elizabeth, Razzouk, Bassem I., Widemann, Brigitte C., Xiao, Shaun, O'Brien, Michelle, Goodspeed, Wendy, Reaman, Gregory H., Blaney, Susan M., Murgo, Anthony J., Balis, Frank M., Adamson, Peter C.

“…Arsenic trioxide (ATO) induces remission in 85% of adults with refractory acute promyelocytic leukemia (APL). We conducted a phase 1 trial of ATO in children…”
Get full text

Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis by Inaba, Hiroto, Fan, Ying, Pounds, Stanley, Geiger, Terrence L., Rubnitz, Jeffrey E., Ribeiro, Raul C., Pui, Ching‐Hon, Razzouk, Bassem I.

“…BACKGROUND. Acute myeloid leukemia (AML) with hyperleukocytosis often is associated with early complications. To the authors' knowledge, no recently published…”
Get full text

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia by Rubnitz, Jeffrey E., Razzouk, Bassem I., Lensing, Shelly, Pounds, Stanley, Pui, Ching‐Hon, Ribeiro, Raul C.

“…BACKGROUND. Outcome after recurrence of childhood acute myeloid leukemia (AML) is poor. We performed this study to identify prognostic factors for recurrence…”
Get full text

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia by JEHA, Sima, RAZZOUK, Bassem, RITCHEY, Kim, ARCECI, Robert, ALTMAN, Arnold, STINE, Kimo, STEINHERZ, Laurel, STEINHERZ, Peter, RYTTING, Michael, RHEINGOLD, Susan, ALBANO, Edythe, KADOTA, Richard, LUCHTMAN-JONES, Lori, BOMGAARS, Lisa, GAYNON, Paul, GOLDMAN, Stewart

“…To determine the efficacy and safety of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia (AML). A phase II, open-label,…”
Get full text

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report by Leger, Kasey J, Absalon, Michael J, Demissei, Biniyam G, Smith, Amanda M, Gerbing, Robert B, Alonzo, Todd A, Narayan, Hari K, Hirsch, Betsy A, Pollard, Jessica A, Razzouk, Bassem I, Getz, Kelly D, Aplenc, Richard, Kolb, E Anders, Ky, Bonnie, Cooper, Todd M

“…Anthracyclines are effective in treating acute myeloid leukemia (AML) but limited by cardiotoxicity. CPX-351, a liposomal daunorubicin and cytarabine, may…”
Get full text

Double-Blind, Placebo-Controlled Study of Quality of Life, Hematologic End Points, and Safety of Weekly Epoetin Alfa in Children With Cancer Receiving Myelosuppressive Chemotherapy by RAZZOUK, Bassem I, HARD, Jeffrey D, HOCKENBERRY, Marilyn, HINDS, Pamela S, FEUSNER, James, WILLIAMS, Denise, RACKOFF, Wayne R

“…To evaluate the effects of once-weekly epoetin alfa (EPO) on health-related quality of life (HRQOL), hemoglobin (Hb), transfusions, and tolerability in…”
Get full text

Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer by Hinds, Pamela S, Hockenberry, Marilyn, Rai, Shesh N, Zhang, Lijun, Razzouk, Bassem I, McCarthy, Kathy, Cremer, Lola, Rodriguez-Galindo, Carlos

“…To describe nocturnal awakenings and sleep environment interruptions experienced by children and adolescents hospitalized for two to four days to receive…”
Get full text

The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01 by Creutzig, Ursula, Zimmermann, Martin, Dworzak, Michael N, Gibson, Brenda, Tamminga, Rienk, Abrahamsson, Jonas, Ha, Shau-Yin, Hasle, Henrik, Maschan, Alexey, Bertrand, Yves, Leverger, Guy, von Neuhoff, Christine, Razzouk, Bassem, Rizzari, Carmelo, Smisek, Petr, Smith, Owen P, Stark, Batia, Reinhardt, Dirk, Kaspers, Gertjan L

“…The prognostic significance of early response to treatment has not been reported in relapsed pediatric acute myeloid leukemia. In order to identify an early…”
Get full text